Of course I’m going to hold on to my shares. I’ve been waiting for years now. Being small and/or having limited funds is no excuse for missing timelines. They should know their limitations and should plan and give prognosis accordingly. It appears they’re doing no such thing and (knowingly?) are being too optimistic to keep shareholders “hooked”.

What happened regarding the TNBC trial is unbelievable. We’re talking about a devastating, lethal sickness, where there is no cure for and a short life expectancy. And somehow the doctors do not have a sense of urgency to treat their patients with Leronlimab? How can that be?
Also, why did it took so long to find out there’s was no sense of urgency?
Did Cydy just wait and wait and just recently tried to find out why no one was injected yet?

Then we have the 8 preclinical trials. Those would be value adding and costing little. Where’s the follow up since february? Where are they, in what order will those be executed and when to expect results?
I could go on and on about empty promises, contradictions, etcetera, etcetera but I won’t, it’s no use and am going to sit it out anyway.
BOL all.